| Identification of novel nitroreductases from Bacillus cereus and their interaction with the CB1954 prodrug VV Gwenin, P Poornima, J Halliwell, P Ball, G Robinson, CD Gwenin Biochemical Pharmacology 98 (3), 392-402, 2015 | 24 | 2015 |
| Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase P Ball, E Thompson, S Anderson, V Gwenin, C Gwenin European Journal of Pharmaceutical Sciences 127, 217-224, 2019 | 13 | 2019 |
| Cell-penetrating peptides as a tool for the cellular uptake of a genetically modified nitroreductase for use in directed enzyme prodrug therapy SD Anderson, RJ Hobbs, VV Gwenin, P Ball, LA Bennie, JA Coulter, ... Journal of functional biomaterials 10 (4), 45, 2019 | 7 | 2019 |
| The YfkO nitroreductase from bacillus licheniformis on gold-coated superparamagnetic nanoparticles: towards a novel directed enzyme prodrug therapy approach P Ball, R Hobbs, S Anderson, E Thompson, V Gwenin, C Von Ruhland, ... Pharmaceutics 13 (4), 517, 2021 | 4 | 2021 |
| Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle‐directed enzyme prodrug therapy as a novel … P Ball, J Halliwell, S Anderson, V Gwenin, C Gwenin Microbiologyopen 9 (10), e1110, 2020 | 4 | 2020 |
| The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach P Ball, E Thompson, S Anderson, V Gwenin, A Ashoorzadeh, J Smaill, ... Bioscience Reports 43 (4), BSR20230627, 2023 | | 2023 |
| Identification and testing of enzymes and prodrugs for use in directed enzyme prodrug therapy strategies for the treatment of cancer P Ball PQDT-UK & Ireland, 2019 | | 2019 |
C D GweninXi'an Jiaotong-Liverpool UniversityVerified email at xjtlu.edu.cn